Dialysis Access—Guidelines for Current Practice  by Huijbregts, H.J.T.A.M. & Blankestijn, P.J.
EDUCATIONAL ARTICLEUpdate on R
educational a
*Correspond
Medical Cen
Utrecht, The
E-mail address
1078–5884/00Dialysis Access—Guidelines for Current Practice
H.J.T.A.M. Huijbregts1,2 and P.J. Blankestijn1*Departments of 1Nephrology, and 2Vascular Surgery, University Medical Centre Utrecht, Utrecht,
The NetherlandsCurrent guidelines promote the use of the native arteriovenous fistula (AVF) as the first choice for access over grafts and
central venous catheters. However, the prevalence of AVF use shows enormous differences among national, regional and local
practice surveys, even after adjusting for demographics. In this review, we will briefly discuss these differences and present
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The ideal vascular access for haemodialysis enables
the dialysis staff to deliver adequate dialysis, has
excellent patency with low complication rates, and is
easy to create. In every day clinical practice 300–
400 mL blood/min is required for the extracorporeal
circuit in order to provide ‘adequate’ dialysis. This is
only possible when the access blood flow is at least
400–500 mL/min. It is well accepted that the native
arteriovenous fistula (AVF) meets best with these
expectations.
In 1997, the K/DOQI Work Group issued evidence
and opinion based guidelines as well as strategies for
implementation to improve quality of life and overall
outcome for haemodialysis patients.1 The primary
objectives of these guidelines are increasing the
placement of native AV fistulae and detecting access
dysfunction prior to access thrombosis. The Vascular
Access Society (www.vascularaccesssociety.com)
recently published clinical algorithms on access care.
They show many similarities with earlier guidelines,
but they emphasize the value of the preoperativeenal Access and Transplantation – one of a series of
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for fistula salvage.2
Several studies have demonstrated striking regional
differences in vascular access care practice.3–6 The
DOPPS study,6 which compared vascular access use at
145 dialysis units in the United States and 101 units in
five European countries, reported that an AVF was
used by 80% of European and 24% of the American
prevalent haemodialysis patients. After adjusting for
age, gender, body mass index, diabetic status, periph-
eral vascular disease, and angina, AVF versus graft use
was still much higher in Europe than the United
States.6 Furthermore, the percentage of AVF use in
these different dialysis units displayed a great range,
varying from 39 to 100% in Europe (median 83%), and
rates as low as 0% AVF use in some American dialysis
units but as high as 87% in other facilities (median
21%),6 (Fig. 1). These findings strongly suggest that a
facility’s practice is predominantly determined by
local preferences and approaches.
In this review, we will discuss factors affecting
outcome of vascular access care and actions poten-
tially improving outcome.The Need for Change
Factors affecting quality and outcome of access care
can be divided into non-modifiable and modifiableEur J Vasc Endovasc Surg 31, 284–287 (2006)
doi:10.1016/j.ejvs.2005.12.004, available online at http://www.sciencedirect.com onved.
Fig. 1. Distribution of arteriovenous fistula (AVF) use among facilities within Europe (EUR) and the United States (US). The
percent of patients using an AVF was determined for a cross-sectional sample of patients within each DOPPS dialysis unit in
EUR and the US. The distribution of AVF use within facilities is shown separately for the US and EUR, and is shown in
increments of 5%. The following percentiles of each distribution are provided for the 10th, 25th, 50th (median), 75th, and 90th
percentiles. (with permission from ref. 6, Blackwell Publishing, UK).
Access Guidelines 285influences. The non-modifiable factors are patient
characteristics such as age, diabetes mellitus and
peripheral vascular disease. The modifiable factors,
on the contrary, appear to be dependent on the
willingness and motivation of decision makers and
include the implementation of protocols, communi-
cation and strategies to meet quality of care standards
(Table 1). Recently, recommendations have been
presented on how to increase the percentage of
prevalent AVFs and optimise surveillance and
patency.7,8
Vascular access care is a classical example of multi-
disciplinary teamwork between nephrologists, vascular
surgeons, interventional radiologists, ultrasound tech-
nicians, and dialysis nurses. To achieve the best outcome
the team must agree on a set of goals, collaborate closely
and maintain good mutual communication. A keyTable 1. Factors involved in vascular access care
Non-modifiable Modifiable
Sex Local protocol differ
Peripheral vascular disease Absence of a multid
Diabetes mellitus CRF-patients startin
Age Absence of standard
Body mass index AVF number and pa
Absence of AVF qua
No radiological inte
No secondary AVF c
No feedback on outcplayer in this multidisciplinary approach is a dedicated
access coordinator who acts as a liaison officer between
the disciplines and schedules the meetings.9 This
person, who may be a nurse, can prospectively monitor
vascular access outcomes and complications, and
evaluate on practice patterns. During meetings he or
she can provide feedback to all decision-makers
enabling them to adjust practice if necessary.
Timely referral may increase the percentage of
patients starting haemodialysis treatment with AVFs
instead of grafts or central venous catheters (CVC).10
Referral for access surgery should be within 6–12
months of the anticipated start of dialysis, i.e. when
glomerular filtration rate (GFR) drops below
25–20 mL/min. This allows ample time for access
maturation or for additional procedures in case of
primary failure.ent from DOQI/European guidelines
isciplinary team
g dialysis over CVC or graft
preoperative duplex examination
tency different from quality of care standards
lity control program
rventions to assist patency in case of failure
reation in graft or catheter patients
ome
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Table 2. Actions potentially improving AVF care
Commitment to adherence to K/DOQI/Vascular Access Society
guidelines
Multidisciplinary and motivated access team
Dedicated vascular access coordinator
Timely referral to nephrologist and vascular surgeon
Vessel mapping prior to surgery referral
Experienced vascular surgeon willing to meet ‘AVF only’
expectations
Monitoring and surveillance programs
Acceptance that primary failures may occur and need additional
interventions
Interventional radiologist performing patency assistance procedures
Secondary AVF creation in AV graft or catheter patients
Outcomes feedback and willingness to adapt to meet care standards
H. J. T. A. M. Huijbregts and P. J. Blankestijn286Finding the best location for fistula placement starts
with the selection of the appropriate vessels. Physical
examination by an experienced vascular surgeon is
indispensable but the addition of preoperative duplex
examination has been proven to influence the choice of
access placement and provides the vascular surgeon
with valuable information.11 A standardised examin-
ation of arteries should record internal diameters,
Doppler waveform analysis and the sites of stenosis
and occlusion. Veins are assessed for compressibility
and internal diameters are measured. Cut-off
thresholds for internal diameters are still debated so
that internal diameter alone cannot fully predict
adequate remodelling but internal diameters of
R2.0 mm for artery and vein for radiocephalic AVFs,
and 3–4 mm for the vein for brachiocephalic or
brachiobasilic AVFs are associated with adequate
maturation, whereas smaller diameters may predict
non-maturation.2
Fistula surgery can be technically challenging. It has
been demonstrated that the type of access placement
varies with individual surgeon practice patterns.12 The
DOPPS study showed that AVF use was significantly
less likely if surgery trainees assisted or performed
vascular access placements.6 Moreover, the odds ratio
of AVF placement is more than three times greater in
high volume centres (O30 access procedures per year)
than in low volume centres (!10 access procedures
per year).12 Thus, only experienced vascular surgeons
who are willing to primarily place AVFs should
construct new accesses.
A fistula is generally ready to be used within 4–6
weeks after placement but primary failure, i.e. early
thrombosis and lack of maturation, occurs in 20–50%
of AVFs.7 Reported patency rates can be misleading
because some investigators have specifically excluded
AVFs that never matured, whereas others have
included these primary failures, leading to compar-
able 1-year cumulative patency rates for AVFs and
grafts. Despite these figures the major advantage of
fistulas over grafts is a better long-term patency with
lower incidences of complications and interventions
once fully matured. The role of the interventional
radiologist in salvaging the failing AVF is very
important. Accessory vein ligation and angioplasty
(PTA) of primary failures can result in a 68–79% 1-year
assisted primary patency.13,14 Such additional inter-
ventions can convert a considerable proportion of
primary non-functioning AVFs to functioning AVFs.
Patients with a functioning fistula (or graft) should
have their access monitored regularly in order to
predict complications. In grafts, access flow measure-
ment seems to be the best method. A graft flow below
600 mL/min is associated with an increased risk ofEur J Vasc Endovasc Surg Vol 31, 3 2006thrombosis.15 Trend analysis by sequential access flow
measurements has been proven to be even more
effective.16,17 In AVFs, access flow below 600 mL/
min does not necessarily predict thrombosis. The
inability to provide a flow of 300–400 mL/min to the
extracorporeal circuit, or the finding of poor dialysis
adequacy, for instance quantified as urea reduction
rates, may help to identify the AVF with insufficient
flow.
Every patient with an AV graft or central venous
catheter should be evaluated for the secondary
placement of an AVF, which is possiblein a consider-
able proportion of such patients allowing the removal
of the catheter.18
The outcome of surgical and radiological interven-
tions should be reported using standard definitions19
in order to compare results with quality of care
standards and modify clinical practice if necessary.
Actions potentially improving vascular access care are
summarised in Table 2.Initiatives for Improvement
The assimilation of recommendations and guidelines
into clinical practice is only possible if all parties
involved are willing and motivated to cooperate.
Single centre experiences have shown that major
improvements in practice patterns can be achieved20
but large scale implementation projects are scarce so
that vascular access distribution has remained roughly
the same since appearance of the K/DOQI guidelines.
In 2003, the United States National Vascular Access
Improvement Initiative (NVAII) launched Fistula First
(http://www.fistulafirst.org). This is a large national
initiative that offers a set of tools for physicians and
dialysis facilities in order to accelerate increasing AVF
use in haemodialysis patients. Eleven change concepts
guide the target groups step-by-step to best practice. In
The Netherlands, the CIMINO-project (Care
Access Guidelines 287Improvement by Multidisciplinary approach for
Increase of Native vascular access Obtainment) was
initiated as an effort to increase AVF use.21 In this
program, vascular access teams are encouraged to
adhere to current guidelines. A vascular access
coordinator registers practice patterns in a newly
developed database. In-centre outcome analysis may
then show the need to improve access care in order to
meet quality of care standards. Hopefully, initiatives
like these result in greater awareness and improve-
ment of patient care.Summary
† Guidelines provide clear evidence based quality of
care standards.
† Practice patterns show great variations.
† Modifiable factors affecting outcome of vascular
access care are identified (Table 1).
† Actions potentially improving outcome of care are
identified (Table 2).
† Success is only possible if not only dialysis staff, but
also surgeons and radiologists regard access care as
their concern.Acknowledgements
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